Glenn P. Muir - Jun 17, 2021 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Director
Signature
/s/ James Stillman Hanson, Attorney-in-Fact
Stock symbol
GTHX
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 04:05 PM
Previous filing
Jun 1, 2021
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +4.39K +2.57% $0.00 175K Jun 17, 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Award $0 +19.6K $0.00 19.6K Jun 17, 2021 Common Stock 19.6K $21.97 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock
F3 Represents 170,969 shares of common stock and 4,389 restricted stock units
F4 The shares underlying this option will vest in their entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.